This is the video recording of our July 1, 2022, Inside Scoop Weekly Strategy Session.
Activists, Options Traders Are Still Bullish on Commodities
As the sleepy summer season carries on, so do the short Hot Lists.
Director Timothy J. Wilmott revealed an acquisition worth $1.2 million in Darden Restaurants $DRI.
Mario Gabelli’s GAMCO Investors filed a 13D revealing an ownership stake of 22.3% in Telesat Corporation $TSAT.
Options Flow Is Bullish for Hertz, Twitter
It’s another brief Hot List today.
Neil Gagnon, the CEO of Gagnon Advisors LLC, revealed a purchase of approximately 43,200 shares in the small-cap software company SecureWorks Corp $SCWX.
Pfizer Reports a Large Stake in Akero Therapeutics
Today’s Hot List is a short one.
Patrick S. Barrett, executive vice-president and CFO of OceanFirst Financial Corp $OCFC, revealed a purchase of approximately 10,500 shares in his own stock.
Buffett’s Berkshire Buys More OXY
The largest insider buy on today’s list is yet another Form 4 filing by Warren Buffett’s Berkshire Hathaway $BRK.A.
Buffett just revealed an additional purchase in Occidental Petroleum $OXY, as he continues to build his position in the energy stock.
Discover Financial’s Bearish Options Flow Stands Out
The largest insider transaction on today’s list is a Form 4 filing by Nimish P. Shah, who reported a purchase of roughly $5.1 million of Tricida $TCDA.
Thomas Meth, the president of Enviva $EVA, reported a purchase of 8,600 shares, equivalent to $505,508 worth of stock.
SNAP Sees a Second Straight Day of Bullish Options Flow
The largest insider buy on today’s list is a Form 4 filing by Turtle Creek Asset Management, which revealed a 496,000-share purchase of JELD-WEN Holding $JELD.
In his latest Form 4, the chairman and CEO of Enviva $EVA revealed a purchase of approximately $1 million in the lumber and wood company.
MTG Buys COST, HD, UPS, and V
The largest insider buy on today’s list is a Form 4 filing by Michael Gladstone, independent director at Day One Biopharmaceuticals $DAWN.
Gladstone disclosed the purchase of approximately $11.5 million worth of shares in the mid-cap biotech company.
- 1
- 2
- 3
- …
- 14
- Next Page »